Antitumor effects of ajulemic acid (CT3), a synthetic non-psychoactive cannabinoid (Q40781309)

23 September 2017

title

Antitumor effects of ajulemic acid (CT3), a synthetic non-psychoactive cannabinoid (English)

1 reference

23 September 2017

0 references

Recht LD

1

1 reference

23 September 2017

Salmonsen R

2

1 reference

23 September 2017

Rosetti R

3

1 reference

23 September 2017

Jang T

4

1 reference

23 September 2017

Pipia G

5

1 reference

23 September 2017

Kubiatowski T

6

1 reference

23 September 2017

Karim P

7

1 reference

23 September 2017

Ross AH

8

1 reference

23 September 2017

Zurier R

9

1 reference

23 September 2017

Litofsky NS

10

1 reference

23 September 2017

Burstein S

11

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

23 September 2017

published in

Biochemical Pharmacology

1 reference

23 September 2017

volume

62

1 reference

23 September 2017

issue

6

1 reference

23 September 2017

page(s)

755-763

1 reference

Antineoplastic Activity of Cannabinoids2

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900700-6

Effects of Marijuana and Tobacco Smoke on Human Lung Physiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900700-6

Delta9-tetrahydrocannabinol induces apoptosis in C6 glioma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900700-6

The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900700-6

Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900700-6

Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900700-6

Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylylcyclase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900700-6

Comparison in mice of pharmacological effects of Δ8-tetrahydrocannabinol and its metabolites oxidized at 11-position

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900700-6

A major metabolite of delta 1-tetrahydrocannabinol reduces its cataleptic effect in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900700-6

Analgesic effects of 1',1' dimethylheptyl-delta8-THC-11-oic acid (CT3) in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900700-6

Dimethylheptyl-THC-11 oic acid: a nonpsychoactive antiinflammatory agent with a cannabinoid template structure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900700-6

Synthetic nonpsychotropic cannabinoids with potent antiinflammatory, analgesic, and leukocyte antiadhesion activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900700-6

Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900700-6

The ring test: a quantitative method for assessing the ‘cataleptic’ effect of cannabis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900700-6

Inhibition of cellular mediated immunity in marihuana smokers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900700-6

Isolation and characterization of two major urinary metabolites of 1 -tetrahydrocannabinol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900700-6

On the metabolism of tritium-labelled Δ1-tetrahydrocannabinol in the rabbit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900700-6

The Metabolism of Δ9-Tetrahydrocannabinol and Related Cannabinoids in Man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900700-6

Protein kinase C and growth regulation of malignant gliomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900700-6

Protein kinase C isoform ? overexpression in C6 glioma cells and its role in cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900700-6

Critical targets of protein kinase C in differentiation of tumour cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900700-6

Diacylglycerol and phosphatidate generated by phospholipases C and D, respectively, have distinct fatty acid compositions and functions. Phospholipase D-derived diacylglycerol does not activate protein kinase C in porcine aortic endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900700-6

Diacylglycerol--when is it an intracellular messenger?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900700-6

Cell cycle regulation of membrane phospholipid metabolism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900700-6

Activity of the phosphatidylcholine biosynthetic pathway modulates the distribution of fatty acids into glycerolipids in proliferating cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900700-6

10.1016/S0006-2952(01)00700-6

7 January 2021

Identifiers

DOI

1 reference

23 September 2017

1 reference